ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
다우존스 지수
38,675.68
1.18%
Bitcoin
63,693.68
-0.31%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Coherus BioSciences Inc (CHRS)

  7. Coherus BioSciences Inc (CHRS) 뉴스

CHRS Coherus BioSciences Inc

2.25
0.08 (3.69%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Coherus BioSciences Inc CHRS 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.08 3.69% 2.25 13:00:01
개장가 저가 고가 종가 전일 종가
2.20 2.19 2.3219 2.27 2.17
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
02/05/202405:30GLOBECoherus to Report First Quarter 2024 Financial Results on..
24/04/202423:02GLOBECoherus Announces Presentation at the 2024 American Society..
08/04/202421:30GLOBECoherus Presents Preclinical Data for CHS-1000, a Novel..
14/03/202405:01GLOBECoherus BioSciences Reports Fourth Quarter, Full Year 2023..
06/03/202406:01GLOBECoherus to Report Fourth Quarter and Full Year 2023..
04/03/202420:22EDGAR2Form 8-K - Current report
04/03/202415:00GLOBECoherus Completes Divestiture of Ophthalmology Franchise
24/02/202407:33GLOBECoherus BioSciences Announces New Employment Inducement..
23/02/202407:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/02/202407:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
23/02/202406:59EDGAR2Form 8-K - Current report
21/02/202422:30GLOBECoherus Announces U.S. Launch of UDENYCA ONBODY™ a Novel and..
05/02/202422:09EDGAR2Form 8-K - Current report
05/02/202422:00GLOBECoherus Amends Term Loan Agreement with Pharmakon Advisors,..
24/01/202410:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/01/202410:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/01/202422:01EDGAR2Form 8-K - Current report
22/01/202415:59DJNSandoz to Acquire Cimerli Business from Coherus for $170..
22/01/202415:15GLOBECoherus Announces Agreement to Divest Ophthalmology..
19/01/202406:05GLOBECoherus Presents Positive Phase 2 Clinical Data on..
10/01/202411:41EDGAR2Form 8-K - Current report
10/01/202411:39EDGAR2Form 8-K - Current report
10/01/202409:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202408:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202407:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202407:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202422:00PRNUSINOVIO and Coherus Announce Clinical Collaboration to..
04/01/202406:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/01/202423:00GLOBECoherus BioSciences Management to Present at the 42nd Annual..
02/01/202422:29GLOBECoherus Announces U.S. Launch of LOQTORZI™
27/12/202323:15APSAnother Biotech Massively Outperforming Broader Equities
27/12/202320:08IHMARKETNEWSWall Street Highlights: Apple Appeals Watch Ban, Tesla to..
27/12/202306:43DJNCoherus BioSciences Gets FDA OK for Udenyca Injector
27/12/202306:01GLOBECoherus Announces FDA Approval of UDENYCA ONBODY™, a Novel..
23/12/202307:00GLOBECoherus BioSciences Announces New Employment Inducement..
16/12/202306:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202306:13EDGAR2Form 8-K - Current report
11/12/202322:30GLOBECoherus Announces Updated NCCN Clinical Practice Guidelines..
08/12/202307:55GLOBECoherus BioSciences Announces CFO Transition Plans
08/12/202307:16EDGAR2Form 8-K - Current report
06/12/202318:00GLOBECoherus Presents Phase 1/2 Clinical Data on Casdozokitug, a..
29/11/202301:16GLOBECoherus and Junshi Biosciences Announce Publication of..
28/11/202306:03EDGAR2Form 8-K - Current report
13/11/202320:07EDGAR2Form 8-K/A - Current report: [Amend]
07/11/202306:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202306:31EDGAR2Form 8-K - Current report
07/11/202306:07GLOBECoherus BioSciences Reports Third Quarter 2023 Financial..
06/11/202320:07EDGAR2Form 8-K/A - Current report: [Amend]
03/11/202321:30GLOBECoherus Presents Data from Next-generation Immuno-oncology..
03/11/202309:00GLOBECoherus BioSciences to Participate at Upcoming November..

최근 히스토리

NASDAQ
CHRS
Coherus BioSciences
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유